Dose response of the BET inhibitor JQ1 in Small-Cell Lung Cancer cell lines.
收藏官方服务：
资源简介：
Dose response of the BET inhibitor JQ1 in Small-Cell Lung Cancer cell lines.
应用场景：
创建时间：
2015-05-31
相关数据集
Protein disulfide isomerase inhibition synergistically enhances the efficacy of sorafenib for hepatocellular carcinoma [SNU761]. Homo sapiens
Sorafenib is the only approved targeted drug for hepatocellular carcinoma (HCC), but its effect on patients’ survival gain is limited and varies over a wide range depending on patho-genetic conditions
NIAID Data Ecosystem60
An Artificial Interfering lncRNA Mediated by Oncolytic Adenovirus Competitively Consumes OncomiRs to Exert Antitumor Efficacy in Hepatocellular Carcinoma (microRNA)
The study generated an artificially-designed interfering long non-coding RNA (lncRNAi). The adenovirus-expressed lncRNAi with high level in hepatocellular carcinoma (HCC) cells competes with OncomiR t
NIAID Data Ecosystem30
DataSheet1_REV1: A novel biomarker and potential therapeutic target for various cancers.PDF
Background: REV1 is a member of the translesion synthesis DNA polymerase Y family. It is an essential player in a variety of DNA replication activities, and perform major roles in the production of bo
NIAID Data Ecosystem20
The Seminoma cell line TCam-2 is Sensitive to HDAC Inhibitor Depsipeptide but Tolerates Various Other Chemotherapeutic Drugs and Loss of NANOG Expression
Genes, Chromosomes and Cancer
Figshare2016-09-01 更新30
DataSheet_2_Synthesis of a New Phenyl Chlormethine-Quinazoline Derivative, a Potential Anti-Cancer Agent, Induced Apoptosis in Hepatocellular Carcinoma Through Mediating Sirt1/Caspase 3 Signaling Pathway.pdf
Quinazoline derivatives display multiple pharmacological activities and target various biological receptors. Based on the skeleton of quinazoline core, we designed and synthesized three new quinazolin
NIAID Data Ecosystem20
